Display options
Cite
Mirzada N, Ladenvall P, Hansson PO, et al. Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA. J Multidiscip Healthc. 2013;6:357-63doi: 10.2147/JMDH.S46890.
Mirzada, N., Ladenvall, P., Hansson, P. O., Eriksson, P., & Dellborg, M. (2013). Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA. Journal of multidisciplinary healthcare, 6357-63. https://doi.org/10.2147/JMDH.S46890
Mirzada, Naqibullah, et al. "Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA." Journal of multidisciplinary healthcare vol. 6 (2013): 357-63. doi: https://doi.org/10.2147/JMDH.S46890
Mirzada N, Ladenvall P, Hansson PO, Eriksson P, Dellborg M. Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA. J Multidiscip Healthc. 2013 Sep 16;6:357-63. doi: 10.2147/JMDH.S46890. PMID: 24082787; PMCID: PMC3785383.
Copy Download .nbib Format: NLM
Share it on

J Multidiscip Healthc. 2013 Sep 16;6:357-63. doi: 10.2147/JMDH.S46890.

Multidisciplinary management of patent foramen ovale (PFO) and cryptogenic stroke/TIA.

Journal of multidisciplinary healthcare

Naqibullah Mirzada, Per Ladenvall, Per-Olof Hansson, Peter Eriksson, Mikael Dellborg

Affiliations

  1. GUCH Centre, Sahlgrenska University Hospital/Östra, Gothenburg, SwedenDept of Molecular and Clinical Medicine/Cardiology, Institute of Medicine, Sahlgrenska Academy Gothenburg University, Gothenburg, Sweden.

PMID: 24082787 PMCID: PMC3785383 DOI: 10.2147/JMDH.S46890

Abstract

PURPOSE: Patent foramen ovale (PFO) has been implicated as a risk factor for cryptogenic ischemic stroke (CS). However, there is still a lack of widely accepted, undisputed indications for PFO closure. The present study describes the concept of the multidisciplinary PFO conference and a decision making process for closure versus no closure that was developed into a formalized clinical algorithm, and presents the results of implementing these, in terms of number and proportion of PFO closures as well as repeat referrals.

DESIGN: Five specialists in neurology, cardiology, internal medicine, thromboembolism, and echocardiography evaluated the clinical data of 311 patients at PFO conferences during 2006 to 2009. The main criteria for closure were patients with first-ever CS with PFO and atrial septal aneurysm, or patients with recurrent CS and PFO without atrial septal aneurysm.

RESULTS: A total of 143 patients (46%) were accepted for closure and 167 patients were rejected. Patients accepted for closure were younger (mean 50 years versus 58 years) (P < 0.001). The acceptance rate for PFO closure was similar throughout these years, with an average of 45%. Three of 167 patients (1.8%) initially rejected for PFO closure were re-referred due to recurrent stroke, and the PFO closure was subsequently performed.

CONCLUSION: The acceptance rate of less than 50% in the present study underscores the complex relationship between CS and PFO. Whatever the criteria used for PFO closure, any unit caring for these patients needs to have a rigorous process to avoid overtreatment as well as undertreatment and to ensure that personal preferences and economic incentives do not steer the selection process. Our algorithm provides a stable acceptance rate and a low rate of repeat referrals.

Keywords: clinical algorithm; cryptogenic stroke; patent foramen ovale; patent foramen ovale closure

References

  1. Neurology. 1996 May;46(5):1301-5 - PubMed
  2. Can J Cardiol. 1999 Jan;15(1):57-64 - PubMed
  3. N Engl J Med. 1988 May 5;318(18):1148-52 - PubMed
  4. Cerebrovasc Dis. 2009;28(4):349-56 - PubMed
  5. N Engl J Med. 2007 Nov 29;357(22):2262-8 - PubMed
  6. Cerebrovasc Dis. 2011;31(2):109-16 - PubMed
  7. N Engl J Med. 2013 Mar 21;368(12):1083-91 - PubMed
  8. Circulation. 2009 May 26;119(20):2743-7 - PubMed
  9. Circulation. 2002 Jun 4;105(22):2625-31 - PubMed
  10. Stroke. 2000 Oct;31(10):2407-13 - PubMed
  11. J Interv Cardiol. 2005 Jun;18(3):173-9 - PubMed
  12. J Am Coll Cardiol. 1992 May;19(6):1192-6 - PubMed
  13. N Engl J Med. 2001 Dec 13;345(24):1740-6 - PubMed
  14. J Am Coll Cardiol. 1994 Jun;23(7):1598-603 - PubMed
  15. J Am Coll Cardiol. 2005 Feb 1;45(3):377-80 - PubMed
  16. J Interv Cardiol. 2006 Jun;19(3):264-8 - PubMed
  17. Lancet. 1988 Jul 2;2(8601):11-2 - PubMed
  18. Stroke. 1994 Apr;25(4):782-6 - PubMed
  19. Neurology. 2000 Oct 24;55(8):1172-9 - PubMed
  20. Stroke. 1998 May;29(5):944-8 - PubMed
  21. Int J Cardiol. 2005 May 11;101(1):77-82 - PubMed
  22. Eur Respir J. 2007 Jan;29(1):149-55 - PubMed
  23. Catheter Cardiovasc Interv. 2006 Nov;68(5):741-6 - PubMed
  24. Am J Cardiol. 1994 Aug 15;74(4):381-4 - PubMed
  25. J Am Coll Cardiol. 2004 Aug 18;44(4):750-8 - PubMed
  26. Can J Neurol Sci. 2006 Feb;33(1):39-47 - PubMed
  27. Mayo Clin Proc. 1984 Jan;59(1):17-20 - PubMed
  28. Stroke. 2005 Jul;36(7):1383-7 - PubMed
  29. Arch Intern Med. 2004 May 10;164(9):950-6 - PubMed
  30. N Engl J Med. 2012 Mar 15;366(11):991-9 - PubMed
  31. N Engl J Med. 2013 Mar 21;368(12):1092-100 - PubMed
  32. Ann Intern Med. 1992 Sep 15;117(6):461-5 - PubMed

Publication Types